Brief: Viracta And XOMA Announce Multi-License Milestone And Royalty Monetization Transaction
23/03/2021 12:17
March 23 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS - XOMA PURCHASED POTENTIAL FUTURE
MILESTONES & ROYALTIES ASSOCIATED WITH EXISTING LICENSES
RELATING TO 2 CLINICAL-STAGE DRUG CANDIDATES
* VIRACTA THERAPEUTICS INC - VIRACTA TO RECEIVE $13.5
MILLION
UPFRONT CASH PAYMENT
Source text for Eikon: ID:nPn4nNCfHa
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update